Newsroom

Press / Medias

LNC Therapeutics Acquires Exclusive License for the Christensenella Patent from Cornell University

Oct 17, 2018

more +
News

LNC Therapeutics acquires exclusive license for the Christensenella patent from Cornell University

Oct 15, 2018

more +
Press / Medias

LNC Therapeutics lance son nouvel essai clinique, OBEMINALE 2, et traite son premier patient

Oct 10, 2018

more +
News

LNC Therapeutics launches a new clinical trial, OBEMINALE 2, and treats its first patient

Oct 2, 2018

more +
Press / Medias

European biotech companies enter IPO prep course

Sep 21, 2018

more +
Press / Medias

The 7 Do’s and Don’ts of Biotech Partnerships

Aug 6, 2018

more +

YSOPIA Bioscience © 2020 - all rights reserved terms and conditions